Skip to main content

Development of Cisplatin Nanoparticles as Dry Powder Inhalers for Lung Cancer

Buy Article:

$55.00 plus tax (Refund Policy)

Dry powder inhalers offer many advantages in the management, prevention and treatment of various respiratory diseases and also with tumors associated with lungs. The present study investigated the feasibility of formulating Cisplatin loaded Gelatin nanoparticles as colloidal drug carriers and converting them into dry powders by coating with inhalable lactose by freeze drying. The average particle size of Cisplatin gelatin nanoparticles was found to be 314 nm by two step desolvation technique. The mean geometric size of the carrier particles was found to be 2.8 ± 0.3 μm. Freeze dried nanoparticles were further mixed with various grades of inhalable lactoses and filled into hard gelatin capsules. In-vitro drug deposition pattern and physicochemical characteristics of nanoparticulate and conventional dry powder inhaler capsule formulation were compared. Results indicated that the developed gelatin nanoparticulate dry powder inhaler capsules possessed higher respirable fraction of 31.4% as compared to conventional dry powder capsule formulation.

The present investigation demonstrates that there is a possibility of delivering the nanoparticles to the lungs by incorporating them into carrier particles by simple adsorption. This provides an innovative path for delivering cytotoxic drugs to the lungs by inhalation.
No References
No Citations
No Supplementary Data
No Data/Media
No Metrics

Keywords: Cisplatin; desolvation; dry powder inhalers; lung cancer; nanoparticles

Document Type: Research Article

Publication date: 2013-08-01

More about this publication?
  • Current Nanoscience publishes authoritative reviews and original research reports, written by experts in the field on all the most recent advances in nanoscience and nanotechnology. All aspects of the field are represented including nano- structures, synthesis, properties, assembly and devices. Applications of nanoscience in biotechnology, medicine, pharmaceuticals, physics, material science and electronics are also covered. The journal is essential to all involved in nanoscience and its applied areas.
  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
X
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more